Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Lupin foundation aims...

    Lupin foundation aims to make 3 districts poverty free by 2022

    Written by Ruby Khatun Khatun Published On 2018-07-08T10:00:22+05:30  |  Updated On 8 July 2018 10:00 AM IST

    Sindhudurg: Lupin Foundation, the CSR arm of pharma company Lupin Ltd, said it will adopt three districts -- one each in Rajasthan, Maharashtra and Madhya Pradesh -- to make them poverty free by 2022.


    "We will adopt Dholpur in Rajasthan, Nadurbar in Maharashtra and Vidisha in Madhya Pradesh under district development programme to make a rural area of these districts poverty free by 2022," Sitaram Gupta, Executive Director, Lupin Welfare and Research Foundation, told reporters here.




    He said the districts have been identified by Niti Ayog "Transformation of Aspirational Districts" and assigned to Lupin Foundation for their development.


    When asked about the money that Lupin Foundation plans to invest in these three districts, Gupta said the company may invest beyond regulatory requirement and for additional funds, if required, it will raise a loan from National Bank for Agriculture and Rural Development (NABARD).


    "The investments will be sourced from Lupin's overall CSR budgets. In a scenario, where the funds required are over and beyond the overall budget allotted, we are open to approaching external agencies like NABARD to meet the demand and ensure the success of the initiative, Gupta said.


    Lupin Foundation claims to have already made rural part of Bharatpur district poverty free by making 20,000 employable by imparting them skill development training and working to train another 30,000 youth.


    "7,000 youth of Bharatpur has been employed as a mason after we trained them. They contributed in making toilets under Swachch Bharat Scheme and are being employed for PM Awas Yojana. Now we are going to make an urban area of Bharatpur poverty free," Gupta said.


    Lupin Foundation has identified 8,000 families in Bharatpur that are below poverty line. It will impart skill development training to them and make them employable.


    Gupta said he is confident of making the new three districts poverty free within a stipulated time frame as the organization already has experience vicinity of two districts- Dholpur and Nandurbar.


    "Under government's Transformation of Aspirational Districts programme, we have to work on 6 parameters including education, health, rural infrastructure, skill development, etc; but in addition to these we will also focus on women empowerment," Gupta said.


    He said Lupin Foundation has partnered with over 10,000 women self-help groups across 4,171 villages to expand its rural development programme.


    At Sindhudurg, Lupin Foundation assisted 60 small-scale entrepreneurs in cashew processing and set-up centre where women entrepreneurs prepare local cuisine for passengers of Indian Railways.

    3 districtsaimsCSRLupinLupin FoundationLupin LtdLupin Welfare and Research FoundationMadhya PradeshmaharashtraNational Bank for Agriculture and Rural DevelopmentNiti Ayogpoverty freeRajasthanSitaram Gupta
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok